The Nifty 50 Index has crashed in the past few days, with technology companies being the top laggards. It was trading at ₹24,765, down 3.65% from the year-to-date high. This article explores the top catalysts for the Nifty Index this month. Nifty 50 Index to react to RBI interest rate decision One of the main

Toyota Motor Corp reported Monday that its global vehicle sales rose for an eighth consecutive month in August, supported by strong demand for hybrid models in the United States despite weaker domestic performance. Worldwide sales increased 2.2 percent year-on-year to 844,963 vehicles, with US sales climbing 13.6 percent. Sales in Japan, by contrast, fell 12.1

Denmark’s Genmab has agreed to acquire Merus NV, a Nasdaq-listed Dutch biotechnology company, in an all-cash transaction valued at $8 billion, the companies announced on Monday. The deal marks a significant expansion of Genmab’s oncology portfolio, adding a promising late-stage cancer therapy candidate to its pipeline. Under the terms of the agreement, Genmab will pay

European shares edged higher on Monday, lifted by gains in healthcare and technology, as investors weighed the risk of a US government shutdown that could delay the release of key economic data. Major European stock indices opened higher on Monday as investors awaited key economic data, including Spain’s inflation and retail sales figures, the UK’s

GSK announced on Monday that Chief Executive Emma Walmsley will step down after nine years in the role, with current Chief Commercial Officer Luke Miels set to take over on January 1. The transition marks a major shift for the UK-based drugmaker as it seeks to define its long-term growth strategy. Walmsley, who took the

Tata Capital Ltd. is preparing India’s biggest share sale of 2025, with its initial public offering seeking to raise up to 155 billion rupees. The deal is designed to expand the company’s tier-1 capital base while meeting regulatory requirements. The financial services arm of Tata Sons will offer as many as 475.8 million shares at

AstraZeneca announced plans to change how it lists shares in the United States by moving from American depositary receipts (ADRs) on Nasdaq to a direct listing of its ordinary shares on the New York Stock Exchange. The decision, revealed on Monday, is part of a broader restructuring of its listing framework to align with its

The TikTok deal has intrigued the markets experts, not just because of its $14 billion price tag but because of what it represents: a rare blend of politics, regulation, and corporate strategy colliding in real time. For many investors, the deal is less about numbers on a balance sheet and more about the precedent it

Following a social media post by US President Donald Trump over the weekend, which suggested potential health benefits from cannabidiol use, shares of cannabis companies rose in early premarket trading on Monday, according to a Reuters report. In a post on Sunday, Trump suggested that cannabidiol (CBD) holds significant promise for the future of senior

BP, a British energy major, announced on Monday its decision to proceed with a $5 billion offshore drilling project in the US Gulf of Mexico.  This move highlights the company’s dedication to rebuilding its oil and gas business in the American region. The Tiber-Guadalupe project, a significant undertaking in the oil and gas sector, is